CFTLF yields 1.28% · JNJ yields 2.14%● Live data
📍 CFTLF pulled ahead of the other in Year 1
Combined, CFTLF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CFTLF + JNJ for your $10,000?
Chinasoft International Limited, together with its subsidiaries, develops and provides information technology (IT) solutions, IT outsourcing, and training services. It operates through Technical Professional Services Group and Internet IT Services Group segments. The company offers CloudEasy, a cloud management platform; Huaxia Cloud, a cloud brokerage platform; Tencent Cloud that provides cloud consultation, migration, operation and maintenance management, and application development and integration; enterprise cloud disk; and cloud shop O2O platform. It also provides IT application development and maintenance, IT testing, infrastructure management, product development and services, digital consulting and implementation, system integration and services, IT consulting and outsourcing, business process outsourcing, and other customer services. In addition, the company offers Internet IT services comprising software industry Internet platform for enterprises. The company serves financial institution, banks, telecommunications and Internet, insurance and securities, retail, high-technology business, manufacturing, transportation, and other industries, as well as to the various government. Chinasoft International Limited was incorporated in 2000 and is headquartered in Beijing, the People's Republic of China.
Full CFTLF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.